This article is more than 5 years old. Information may no longer be current.

Five glaucoma headlines you might have missed

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Recent advancements in glaucoma include a new European clinical trial and a CPT code for a popular IOP-lowering treatment.

Here are five recent glaucoma-related stories you might have missed:

1. Open-angle glaucoma may be associated with stroke risk

A 10-year retrospective study found an increased stroke risk in those with open-angle glaucoma. Read more.

2. CyPass micro-stent CPT code becomes effective

The CyPass micro-stent, a minimally invasive glaucoma surgical device, now has a Category 3 code. Read more.

3. Long-term data reinforce positive effect of phacoemulsification for glaucoma

A systematic review and meta-analysis confirmed the IOP-lowering effect of phacoemulsification alone in patients with primary open-angle glaucoma and the consequent reduction in the use of medications. Read more.

4. Majority of patients able to measure own IOP in study

A study found 73% of patients were successfully able to use a rebound tonometer to perform self-tonometry and obtain an IOP reading within 5 mm Hg of a clinician. Read more.

5. Phase 3 trial of Roclatan begins in Europe

Aerie Pharmaceuticals began patient dosing in a phase 3 European trial of Roclatan for lowering IOP. Read more.